The nutraceutical industry is growing by leaps and bounds owing to scores of product launches and conducive regulatory environment for them.
Dietary Supplements –
Dietary supplements are orally consumed products that complement the diet and contain vitamins, minerals, amino acids, plant extracts, or other bioactive substances.
Functional Foods –
Functional foods are conventional foods fortified with additional nutrients or bioactive compounds to provide health benefits beyond basic nutrition.
Medical Foods –
Medical foods are specially formulated and processed for the nutritional management of diseases or disorders and must be consumed under medical supervision.
Regulatory Influence on Market Access and Labelling- Marketing: If the product requires scientific proof, or make health claims such as 'support for immune function'
- Labelled: Contains warnings, dosing guidelines, and ingredient lists.
- Approval for Sale: Some products, such as medical foods, require pre-market approval, whereas others, like dietary supplements in the US, can be marketed under self-regulation.
The regulatory environments for nutraceuticals vary significantly across different regions, reflecting diverse cultural, economic, and legal contexts.
Under the Food Safety and Standards Act (FSSA) of 2006, the Ministry of Health and Family Welfare introduced the Food Safety and Standards Authority of India (FSSAI) which oversees the regulation of the nutraceutical sector. Recent changes aim to improve compliance, expedite approvals, and promote innovation through research.
Important Regulatory Shifts
1. Streamlined Approval Procedures
The FSSAI implemented a pre-approved ingredient list to expedite product approvals.
An online FoSCoS (Food Safety Compliance System) – FSSAI licensing system was introduced to facilitate quicker registration and compliance monitoring.
2. Stronger Compliance Mechanisms
Updated Recommended Dietary Allowance (RDA) limits for bioactives, vitamins, and minerals to align with safety regulations.
Prohibition of unapproved herbal substances lacking scientific validation.
Stricter labelling regulations to prevent deceptive health claims.
Enhanced import regulations to ensure foreign products meet Indian safety standards.
3. Encouraging Scientific Research
Collaborations with ICMR, CSIR, and NIFTEM for clinical validation of nutraceuticals.
Integration of scientific standards for Ayurvedic nutraceuticals in partnership with the Ministry of AYUSH.
Incentives for clinical trials, research, and plant-based nutrition innovation.
In the United States, the Dietary Supplement Health and Education Act (DSHEA) of 1994 regulates dietary supplements. Under DSHEA, the Food and Drug Administration (FDA) oversees the industry but does not require pre-market approval for dietary supplements. The Federal Trade Commission (FTC) monitors advertising and marketing claims to ensure they are not misleading. Recent regulatory changes emphasise Good Manufacturing Practices (GMPs), ingredient safety, and post-market surveillance.
The European Union has one of the most stringent regulatory frameworks for nutraceuticals. Products often fall under the Novel Foods Regulation (EU) 2015/2283, which require pre-market authorisation and scientific validation of health claims. The EU Nutrition and Health Claims Regulation (EC) No 1924/2006 governs the use of health claims, allowing only those supported by strong scientific evidence.
China regulates nutraceuticals under two distinct systems. While general dietary supplements must adhere to national food safety requirements, health foods must be pre-registered with the State Administration for Market Regulation.
Strict regulations compel companies to invest in scientific research to substantiate product claims and ensure safety. However, these regulations may also slow innovation by increasing costs and approval times. For example, probiotics in the EU must undergo rigorous clinical trials before making health claims, limiting the introduction of new products.
Regulatory reforms enhance consumer trust by enforcing safety standards and clear labelling. Programmes like the FDA's dietary supplement verification initiative and similar measures in Europe have strengthened market credibility.
Regulatory discrepancies create non-tariff barriers, complicating global trade. Businesses must navigate varying import regulations, labelling requirements, and safety standards, increasing operational complexity.
The EU’s stringent regulations on probiotics, including restrictions on the term "probiotic" and rigorous health claim requirements, have shaped the market significantly. While these measures protect consumers and maintain scientific credibility, they have also hindered product innovation, increased compliance costs, and created market uncertainty.
India’s herbal supplement industry is transforming due to evolving regulations, quality control measures, and scientific validation efforts. While stricter regulations have enhanced product safety, consumer trust, and global market access, they have also posed challenges for small manufacturers by increasing compliance costs.
Challenges
1. Regulatory Complexity- Varying regulations across countries create difficulties for companies navigating multiple legal frameworks.
- A product approved under DSHEA in the US may not be accepted in the EU due to stricter health claim requirements.
2. Compliance Costs- High investments in scientific research, clinical trials, and documentation are necessary to meet regulatory standards.
- Testing for safety, efficacy, and label accuracy increases manufacturing expenses.
3. Market Entry Barriers- Lengthy approval processes for new ingredients and health claims.
- The EU's stringent EFSA regulations have delayed the approval of probiotic health claims.
Opportunities1. Innovation- Regulatory guidelines encourage the development of high-quality, scientifically backed products.
- AI-driven personalised nutrition is gaining traction in response to regulatory demands.
2. Global Market Expansion- Companies meeting stringent regulatory standards gain a competitive advantage in international markets.
- Nutraceuticals certified under both US FDA and EU EFSA regulations are perceived as high quality, enhancing global consumer trust.
3. Consumer Trust and Safety- Strict regulations eliminate substandard products from the market.
- Transparent labelling builds consumer confidence in dietary supplements and functional foods.
Future Perspectives The nutraceutical industry is constantly evolving, with upcoming regulatory trends shaping its trajectory.
1. Regulatory Harmonisation- Organisations like the Codex Alimentarius Commission are working towards standardising regulations to ease international trade barriers.
- ASEAN is developing regional guidelines for nutraceuticals to simplify market access.
2. Personalised Nutrition and Precision Supplements- Advances in genomics, microbiome research, and AI-driven dietary recommendations are revolutionising nutraceuticals.
- Countries like the US and Japan are exploring regulatory pathways for precision nutrition.
3. Digital Transparency and Blockchain in Nutraceuticals- Blockchain technology can improve supply chain transparency and prevent fraud.
- Consumers can verify product claims in real time, enhancing brand credibility.
4. Stronger Regulations for Health Claims- Future laws may require more robust scientific proof for health claims.
- The European Food Safety Authority already mandates clinical trial-level evidence, a practice likely to expand globally.
5. Sustainability in Nutraceutical Production- Regulations are emerging for sustainable sourcing of plant-based ingredients, waste reduction, and eco-friendly packaging.
- Governments may introduce green certification programmes for nutraceutical companies.
(Dr Kaur is assistant professor, Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow campus. She can be reached at gkaur@lko.amity.edu; Dr Awasthi is assistant professor, Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow campus. He can be reached at vawasthi@lko.amity.edu)